Clinical trials: Microsatellite Stable Relapsed or Refractory Colorectal Cancer
Microsatellite Stable Relapsed or Refractory Colorectal Cancer
A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
This is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer. The primary objective of Part 1 is to evaluate the safety and tolerability of escalating doses of eFT508 in…
- Trial name
- NCT03258398
- Testing
- eFT508, Avelumab
- Where
- 7 sites in United States
- Volunteers
- 56 people
- Sponsor
- Effector Therapeutics